Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 87 articles:
HTML format
Text format



Single Articles


    October 2017
  1. SPENGLER EK, O'Leary JG, Te HS, Rogal S, et al
    Liver Transplantation in the Obese Cirrhotic Patient.
    Transplantation. 2017;101:2288-2296.
    PubMed     Text format     Abstract available


    September 2017
  2. CITRO A, Cantarelli E, Pellegrini S, Dugnani E, et al
    Antiinflammatory strategies in intrahepatic islet transplantation: a comparative study in preclinical models.
    Transplantation. 2017 Sep 8. doi: 10.1097/TP.0000000000001925.
    PubMed     Text format     Abstract available


  3. WEICHEN Z, Feibo L, Yufu Y, Yuanxing L, et al
    Isoglycyrrhizinate magnesium enhances hepatoprotective effect of FK506 on ischemia-reperfusion injury through HMGB1 inhibition in a rat model of liver transplantation.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001941.
    PubMed     Text format     Abstract available


  4. SNEIDERS D, Houwen T, Pengel LHM, Polak WG, et al
    Systematic review and meta-analysis of posttransplant hepatic artery and biliary complications in patients treated with transarterial chemoembolization before liver transplantation.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001936.
    PubMed     Text format     Abstract available


    August 2017
  5. DOSHI SD, Bittermann T, Schiano TD, Goldberg DS, et al
    Waitlisted Candidates With Polycystic Liver Disease Are More Likely to be Transplanted Than Those With Chronic Liver Failure.
    Transplantation. 2017;101:1838-1844.
    PubMed     Text format     Abstract available


  6. ICHAI P, Laurent-Bellue A, Saliba F, Moreau D, et al
    Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors.
    Transplantation. 2017;101:1830-1837.
    PubMed     Text format     Abstract available


    July 2017
  7. BOYLAN JM, Francois-Vaughan H, Gruppuso PA, Sanders JA, et al
    Engraftment and Repopulation Potential of Late Gestation Fetal Rat Hepatocytes.
    Transplantation. 2017 Jul 27. doi: 10.1097/TP.0000000000001882.
    PubMed     Text format     Abstract available


  8. LI Y, Ma D, Wang Z, Yang J, et al
    MicroRNA-155 Deficiency in Kupffer Cells Ameliorates Liver Ischemia-Reperfusion Injury in Mice.
    Transplantation. 2017;101:1600-1608.
    PubMed     Text format     Abstract available


  9. DUBROCK HM, Goldberg DS, Sussman NL, Bartolome SD, et al
    Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    Transplantation. 2017;101:1609-1615.
    PubMed     Text format     Abstract available


  10. JOCHMANS I, van Rosmalen M, Pirenne J, Samuel U, et al
    Adult Liver Allocation in Eurotransplant.
    Transplantation. 2017;101:1542-1550.
    PubMed     Text format     Abstract available


    June 2017
  11. KIM PT, Klintmalm GB
    Authors' Reply: Does low Hepatic Artery Flow Increase Rate of Biliary Strictures in Deceased Donor Liver Transplantation?
    Transplantation. 2017 Jun 21. doi: 10.1097/TP.0000000000001855.
    PubMed     Text format    


    May 2017
  12. EMOND JC, Goodrich NP, Pomposelli JJ, Baker TB, et al
    Hepatic hemodynamics and portal flow modulation: The A2ALL experience.
    Transplantation. 2017 May 17. doi: 10.1097/TP.0000000000001823.
    PubMed     Text format     Abstract available


  13. KENSINGER CD, Feurer ID, Karp SJ
    An Outcome-Based Approach to Assign MELD Exception Points for Patients With Hepatocellular Cancer.
    Transplantation. 2017 May 4. doi: 10.1097/TP.0000000000001812.
    PubMed     Text format     Abstract available


  14. CHENG XS, Stedman MR, Chertow GM, Kim WR, et al
    Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation.
    Transplantation. 2017;101:1111-1119.
    PubMed     Text format     Abstract available


    March 2017
  15. MEHTA N, Heimbach J, Lee D, Dodge JL, et al
    Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot".
    Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001752.
    PubMed     Text format     Abstract available


  16. BHATI C, Idowu MO, Sanyal AJ, Rivera M, et al
    Long Term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis Related Cirrhosis.
    Transplantation. 2017 Mar 15. doi: 10.1097/TP.0000000000001709.
    PubMed     Text format     Abstract available


  17. MURALI AR, Patil S, Phillips KT, Voigt M, et al
    Locoregional Therapy with Curative Intent versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-analysis.
    Transplantation. 2017 Mar 10. doi: 10.1097/TP.0000000000001730.
    PubMed     Text format     Abstract available


  18. LAI Q, Feys E, Karam V, Adam R, et al
    Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry.
    Transplantation. 2017;101:555-564.
    PubMed     Text format     Abstract available


    February 2017
  19. PALUMBO T, Nakamura K, Lassman C, Kidani Y, et al
    Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model.
    Transplantation. 2017;101:322-331.
    PubMed     Text format     Abstract available


  20. REDDY MS, Rajalingam R, Rela M
    Revisiting APOLT for Metabolic Liver Disease: A New Look at an Old Idea.
    Transplantation. 2017;101:260-266.
    PubMed     Text format     Abstract available


    January 2017
  21. BITTERMANN T, Goldberg DS, Bauer CM, Khungar V, et al
    Characterizing the risk of false-positive hepatocellular carcinoma in recipients transplanted with T2 MELD exceptions.
    Transplantation. 2017 Jan 25. doi: 10.1097/TP.0000000000001660.
    PubMed     Text format     Abstract available


  22. SATAPATHY SK, Vanatta JM, Helmick R, Flowers A, et al
    Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.
    Transplantation. 2017 Jan 17. doi: 10.1097/TP.0000000000001647.
    PubMed     Text format     Abstract available


  23. VINAIXA C, Strasser SI, Berenguer M
    DISEASE REVERSIBILITY IN PATIENTS WITH POSTHEPATITIS C CIRRHOSIS: IS THE POINT OF NO RETURN THE SAME BEFORE AND AFTER LIVER TRANSPLANTATION? A REVIEW.
    Transplantation. 2017 Jan 6. doi: 10.1097/TP.0000000000001633.
    PubMed     Text format     Abstract available


  24. RICH N, Tanriover B, Singal AG, Marrero JA, et al
    Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Transplantation. 2017;101:e12-e19.
    PubMed     Text format     Abstract available


  25. LIU D, Chan AC, Fong DY, Lo CM, et al
    Evidence-Based Surveillance Imaging Schedule After Liver Transplantation for Hepatocellular Carcinoma Recurrence.
    Transplantation. 2017;101:107-111.
    PubMed     Text format     Abstract available


  26. DEMARTINO ES, Cartin-Ceba R, Findlay JY, Heimbach JK, et al
    Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation.
    Transplantation. 2017;101:101-106.
    PubMed     Text format     Abstract available


    December 2016
  27. KIM PT, Fernandez H, Gupta A, Saracino G, et al
    Low measured hepatic artery flow increases rate of biliary strictures in deceased donor liver transplantation: An age dependent phenomenon.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  28. LAI Q, Feys E, Karam V, Adam R, et al
    HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  29. SALAZAR J, Saxena V, Kahn JG, Roberts JP, et al
    Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    November 2016
  30. MURALI AR, Romero-Marrero C, Miller C, Aucejo F, et al
    Predictors of Successful Downstaging of Hepatocellular Carcinoma Outside Milan Criteria.
    Transplantation. 2016;100:2391-2397.
    PubMed     Text format     Abstract available


  31. ZAHR ELDEEN F, Roll GR, Derosas C, Rao R, et al
    Preoperative Thromboelastography as a Sensitive Tool Predicting Those at Risk of Developing Early Hepatic Artery Thrombosis After Adult Liver Transplantation.
    Transplantation. 2016;100:2382-2390.
    PubMed     Text format     Abstract available


  32. KRAWCZYK M, Grat M, Adam R, Polak WG, et al
    Liver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant Registry.
    Transplantation. 2016;100:2372-2381.
    PubMed     Text format     Abstract available


    August 2016
  33. POMPOSELLI JJ
    Hepatic Artery Thrombosis (HAT) After Liver Transplant: Not A Surgical Problem?
    Transplantation. 2016.
    PubMed     Text format    


  34. MOHKAM K, Fanget F, Darnis B, Harbaoui B, et al
    Use of systemic vasodilators for the management of Doppler ultrasound arterial abnormalities after orthotopic liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  35. FURUICHI M, Fujiwara T, Fukuda A, Kasahara M, et al
    Fulminant hepatic failure as a risk factor for cytomegalovirus infection in children receiving preemptive therapy after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  36. TAPPER EB, Hughes MS, Buti M, Dufour JF, et al
    The optimal timing of hepatitis C therapy in transplant eligible patients with Child B and C Cirrhosis: A Cost-Effectiveness Analysis.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  37. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Proposal of Muscle-MELD score, including muscularity, for prediction of mortality after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  38. CICALESE L, Shirafkan A, Jennings K, Zorzi D, et al
    Increased risk of death for patients on the waitlist for liver transplant residing at greater distance from specialized liver transplant centers in the USA.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  39. HART A, Schladt DP, Zeglin J, Pyke J, et al
    Predicting outcomes on the liver transplant waiting list in the United States: Accounting for large regional variation in organ availability and priority allocation points.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  40. MURALI AR, Chandra S, Stewart Z, Blazar BR, et al
    Graft versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    July 2016
  41. GYOTEN K, Mizuno S, Kato H, Murata Y, et al
    A novel predictor of posttransplant portal hypertension in adult-to-adult living donor liver transplantation: increased estimated spleen/graft volume ratio.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  42. GOODRICH NP, Schaubel DE, Smith AR, Merion RM, et al
    National Assessment of Hospitalization Rates for Incident End Stage Renal Disease after Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  43. SIMKINS J, Abbo LM, Camargo JF, Rosa R, et al
    Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  44. KROWKA MJ, Fallon MB, Kawut SM, Fuhrmann V, et al
    International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.
    Transplantation. 2016;100:1440-52.
    PubMed     Text format     Abstract available


  45. SULLIVAN T, Weinberg A, Rana M, Patel G, et al
    The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  46. POMPOSELLI JJ, Goodrich NP, Emond JC, Humar A, et al
    Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
    Transplantation. 2016;100:1490-9.
    PubMed     Text format     Abstract available


    June 2016
  47. HAN S, Yang JD, Sinn DH, Ko JS, et al
    Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  48. GEISSLER EK, Schnitzbauer AA, Schlitt HJ
    A Rebuttal Letter in Response to: Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  49. CHOLONGITAS E
    Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  50. HSU CC, Chen CL, Wang CC, Lin CC, et al
    Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  51. WANG CW, Feng S, Covinsky KE, Hayssen H, et al
    A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  52. SALVALAGGIO PR, Seda Neto J, Alves JA, Fonseca EA, et al
    Consensus, Dilemmas, and Challenges in Living Donor Liver Transplantation in Latin America.
    Transplantation. 2016;100:1161-4.
    PubMed     Text format     Abstract available


    May 2016
  53. DEW MA, DiMartini AF, Ladner DP, Simpson MA, et al
    Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    April 2016
  54. DE CARLIS L, Lauterio A, De Carlis R, Ferla F, et al
    Donation After Cardiac Death Liver Transplantation After More Than 20 Minutes of Circulatory Arrest and Normothermic Regional Perfusion.
    Transplantation. 2016;100:e21-2.
    PubMed     Text format    


  55. KIMURA K, Shirabe K, Yoshizumi T, Takeishi K, et al
    Ischemia-Reperfusion Injury in Fatty Liver Is Mediated by Activated NADPH Oxidase 2 in Rats.
    Transplantation. 2016;100:791-800.
    PubMed     Text format     Abstract available


    March 2016
  56. SEDA-NETO J, Antunes da Fonseca E, Pugliese R, Candido HL, et al
    Twenty Years of Experience in Pediatric Living Donor Liver Transplantation: Focus on Hepatic Artery Reconstruction, Complications and Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  57. CAO Y, Shahrestani S, Chew HC, Crawford M, et al
    Donation After Circulatory Death for Liver Transplantation: A Meta-Analysis on the Location of Life Support Withdrawal Affecting Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  58. VANDEKERCKHOVE K, Coomans I, De Bruyne E, De Groote K, et al
    Evaluation of Exercise Performance, Cardiac Function, and Quality of Life in Children After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  59. KHORSANDI SE, Yip VS, Cortes M, Jassem W, et al
    Does Donation After Cardiac Death Utilization Adversely Effect Hepatocellular Cancer Survival?
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  60. FOSTER BJ, Dahhou M, Zhang X, Dharnidharka VR, et al
    High Risk of Liver Allograft Failure During Late Adolescence and Young Adulthood.
    Transplantation. 2016;100:577-84.
    PubMed     Text format     Abstract available


    February 2016
  61. WESTERKAMP AC, Karimian N, Matton AP, Mahboub P, et al
    Oxygenated Hypothermic Machine Perfusion After Static Cold Storage Improves Hepatobiliary Function of Extended Criteria Donor Livers.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  62. TOUSSAINT A, Weiss E, Khoy-Ear L, Janny S, et al
    Prognostic Value of Preoperative Brain Natriuretic Peptide Serum Levels in Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  63. ZHOU H, Zhu J, Yue S, Lu L, et al
    The Dichotomy of Endoplasmic Reticulum Stress Response in Liver Ischemia-Reperfusion Injury.
    Transplantation. 2016;100:365-72.
    PubMed     Text format     Abstract available


    January 2016
  64. POURCHER G, El-Kehdy H, Kanso F, Groyer-Picard MT, et al
    Volumetric Portal Embolization: A New Concept to Improve Liver Regeneration and Hepatocyte Engraftment.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  65. POMFRET EA
    Killing Two Birds With One Stone: Antineoplastic Immunosuppression.
    Transplantation. 2016;100:14-5.
    PubMed     Text format    


  66. LEUVENINK HG
    Warming Up--Not Only Essential for Athletes?
    Transplantation. 2016;100:10-1.
    PubMed     Text format    


  67. HOYER DP, Mathe Z, Gallinat A, Canbay AC, et al
    Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept.
    Transplantation. 2016;100:147-52.
    PubMed     Text format     Abstract available


  68. VIJGEN S, Wyss C, Meylan P, Bisig B, et al
    Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.
    Transplantation. 2016;100:134-40.
    PubMed     Text format     Abstract available


    December 2015
  69. TANIMINE N, Tanaka Y, Abe T, Piao J, et al
    Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  70. DOYCHEVA I, Leise MD, Watt KD
    The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    November 2015
  71. MAS V, Archer KJ, Maluf D
    The High-Risk Age Window After Pediatric Liver Transplantation: Modeling Allograft Loss Using Mathematical Tools.
    Transplantation. 2015.
    PubMed     Text format    


  72. MARIANTE-NETO G, Brandao AB
    Model for End-Stage Liver Disease: Is Sex-Based Creatinine Correction a Viable Strategy for Black Females?
    Transplantation. 2015;99:2337-40.
    PubMed     Text format     Abstract available


  73. NOBEL YR, Goldberg DS
    Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.
    Transplantation. 2015;99:2341-6.
    PubMed     Text format     Abstract available


    September 2015
  74. CHOI Y, Yi NJ, Ko JS, Moon JS, et al
    Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  75. MANGUS RS, Fridell JA, Kubal CA, Loeffler AL, et al
    Worse Long-term Patient Survival and Higher Cancer Rates in Liver Transplant Recipients With a History of Smoking.
    Transplantation. 2015;99:1862-1868.
    PubMed     Text format     Abstract available


  76. MANGUS RS, Lutz AJ, Fridell JA, Kubal CA, et al
    Minimal Improvement in Glomerular Filtration Rate in the First Year After Liver Transplantation.
    Transplantation. 2015;99:1855-1861.
    PubMed     Text format     Abstract available


  77. ERICZON BG, Wilczek HE, Larsson M, Wijayatunga P, et al
    Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
    Transplantation. 2015;99:1847-1854.
    PubMed     Text format     Abstract available


  78. PARAJULI S, Foley D, Djamali A, Mandelbrot D, et al
    Renal Function and Transplantation in Liver Disease.
    Transplantation. 2015;99:1756-64.
    PubMed     Text format     Abstract available


  79. IACOB S, Cicinnati VR, Lindemann M, Heinemann FM, et al
    Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.
    Transplantation. 2015;99:1869-75.
    PubMed     Text format     Abstract available


    June 2015
  80. GHABRIL M, Agarwal S, Lacerda M, Chalasani N, et al
    Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    May 2015
  81. CHENG Q, He SQ, Gao D, Lei B, et al
    Early Application of Auxiliary Partial Orthotopic Liver Transplantation in Murine Model of Wilson Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  82. HAYASHI K, Uchida H, Takaoka C, Izawa Y, et al
    Discrepancy in Psychological Attitudes Toward Living Donor Liver Transplantation Between Recipients and Donors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  83. LONGENECKER JC, Estrella MM, Segev DL, Atta MG, et al
    Patterns of Kidney Function Before and After Orthotopic Liver Transplant: Associations With Length of Hospital Stay, Progression to End-Stage Renal Disease, and Mortality.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  84. MOROSO V, van Cranenbroek B, Mancham S, Sideras K, et al
    Prominent HLA-G Expression in Liver Disease But Not After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    March 2015
  85. SCHIEFER J, Lebherz-Eichinger D, Erdoes G, Berlakovich G, et al
    Alterations of Endothelial Glycocalyx During Orthotopic Liver Transplantation in Patients With End-Stage Liver Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    February 2015
  86. MANCIA C, Loustaud-Ratti V, Carrier P, Naudet F, et al
    Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    January 2015
  87. OEZCELIK A, Dayangac M, Guler N, Yaprak O, et al
    Living Donor Liver Transplantation in Patients 70 Years or Older.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: